PITPNM2-AS1

Across TCGA pan-cancer cohorts, PITPNM2-AS1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated PITPNM2-AS1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher PITPNM2-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PITPNM2-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.

UCS, UVM, and KIRC are the cancer types where PITPNM2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	All	0.508	0.157	<.001	82	view →
UVM	OS	Quartile	III,IV	0.231	0.848	.002	50	view →
KIRC	OS	Quartile	II,III,IV	0.388	0.665	.001	50	view →
ACC	OS	Tertile	All	0.587	0.937	.006	48	view →
LGG	OS	Tertile	All	0.910	0.747	<.001	37	view →
COAD	OS	Tertile	III,IV	0.654	0.894	.002	33	view →
OV	OS	Median	IV	0.571	0.903	<.001	22	view →
LUSC	OS	Median	All	0.613	0.696	.025	21	view →
LUAD	DFS	Median	III,IV	0.285	0.629	.002	20	view →
PCPG	DFS	Quartile	All	0.584	0.885	.013	19	view →
ESCA	OS	Tertile	III,IV	0.702	0.250	.001	18	view →
THYM	OS	Median	All	0.970	0.720	.002	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

PITPNM2-AS1–UCS (DFS)

Open the UCS breakdown →